ClinicalTrials.govpublic full text
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers
aggressive variant prostate carcinoma, castration-resistant prostate carcinoma, metastatic clear cell renal cell carcinoma, metastatic malignant solid neoplasm, metastatic prostate carcinoma, metastatic urothelial carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 256862
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.